All In Biotech

Drug Trial Radar · NCT00115063

LOSS- Louisiana Obese Subjects Study

Loss - Louisiana Obese Subjects Study

Last checked: Nov 20, 2026Latest source record: Feb 22, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 390 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

390

Actual

Start

Jul 2005

Primary completion

Dec 2007

Study completion Jan 2008

Sponsor

Lead sponsor
Pennington Biomedical Research CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Louisiana Office of Group Benefits
First posted
Jun 21, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 20 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

LOSS is a pragmatic clinical evaluation of intensive medical approaches to weight loss for individuals with extreme obesity (body mass index \[BMI\] 40-60 kg/m2). The intensive medical treatment is designed to produce 25% weight loss from baseline and to maintain at least 20% weight loss from baseline. The intensive medical treatment is compared to a usual care treatment model where individuals utilize self directed approaches to weight loss. The active treatment period is three years, followed by two years of observation.

Conditions

  • Obesity

Interventions

  • group sessionsBehavioral

    group sessions lead by a trained primary care clinic employee

  • sibutramine, orlistat, diethylpropionDrug

    dosage modified according to package insert instructions at discretion of primary care physicians

  • Low Calorie Diet, Health OneBehavioral

    liquid diet for 8-12 weeks to induce weight loss

  • Intensive Medical Combination Therapy for ObesityOther

    Very Low Calorie Liquid diet, Group Behavioral Therapy, Meal Replacement Therapy, Obesity Pharmacotherapy and a "Treatment Toolbox".

  • Control ConditionOther

    Access to the Mayo Clinic weight management website and usual care from the primary care physician

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline WeightTime frame: Baseline, 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Pennington Management of Clinical Trials

    Baton Rouge, Louisiana

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.